Strikingly, MSI1 is co-expressed with CD44 in single neoplastic cells at the invasive front of GBMs, supporting the view that MSI1′s role in promoting stem cell properties in gliomas essentially relies on the impairment of miRNA-directed downregulation of stem cell markers like CD44. The gene discussed is CD44; the disease is central nervous system cancer.